[Was chemotherapy beneficial for the patients with advanced ovarian cancer? A comparison of survival and resource use in two different time periods].
Around 1980, aggressive surgery and combination-chemotherapy were introduced as routine therapy in advanced ovarian cancer. It is interesting to evaluate whether this has been associated with an improvement of survival. A comparison between patients diagnosed in the county of Funen during the period April 1973 to April 1978 with patients diagnosed during the period September 1981 to September 1986 was made. In the last period the patients were treated according to the DACOVA guidelines (Damish Cancer of the Ovaries). An improvement in median survival but not in five-year survival was registered. The number of hospital bed-days during the two periods was calculated. In the second period the number of hospital bed-days was seven days higher per patient than in the first period. The cost per gained year of life was 240,000 Dkr. in 1992 prices.
Bertelsen
K
K
Onkologisk afdeling, Odense Universitetahospital.
Kruhøffer
A
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001509:Bed Occupancy; D002945:Cisplatin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003718:Denmark / Q000453:epidemiology; D005260:Female; D006801:Humans; D007902:Length of Stay; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D015996:Survival Rate
D002945:Cisplatin